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Abstract
Background: Genetic studies on Acyl-CoA Synthetase Long-Chain 5 (ACSL5) demonstrate an association between
rs2419621 genotype and rate of weight loss in women with obesity in response to caloric restriction. Our objectives
were to (1) confirm results in two different populations of women with overweight and obesity (2) study
rs2419621’s influence on body composition parameters of women with overweight and obesity following lifestyle
interventions.
Methods: rs2419621 genotype was determined in women with overweight and obesity who participated in the
Montréal-Ottawa New Emerging Team (MONET n = 137) and Complications Associated with Obesity (CAO n = 37)
studies. Genotyping was done using TaqMan MGB probe-based assay. Multiple linear regression analyses were used
to test for associations.
Results: When studying women with overweight and obesity, rs2419621 [T] allele carriers had a significantly greater
decrease in visceral fat, absolute and percent fat mass and a greater increase in percent lean mass in response to
lifestyle intervention in comparison to non-carriers. Studying only individuals with obesity showed similar results
with rs2419621 [T] allele carriers also displaying a significantly greater decrease in body mass index following the
lifestyle intervention in comparison to non-carriers.
Conclusion: Women with overweight and obesity carrying the ACSL5 rs2419621 [T] allele are more responsive to
lifestyle interventions in comparison to non-carriers. Conducting such genetic association studies can aid in
individualized treatments/interventions catered towards an individual’s genotype.
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Background
Obesity, recently defined as a disease by the American
Medical Association, and overweight are major risk
factors for a variety of chronic diseases including cardio-
vascular diseases, type 2 diabetes and cancer [1]. Genetic
and epigenetic mechanisms, mediated by lifestyle and
environmental exposures have been implicated in the
development of obesity and these chronic diseases [2, 3].
As a critical component of metabolic pathways, fatty
acyl-CoA molecules are known to be implicated in en-
ergy production by β-oxidation, energy storage through
lipid biosynthesis and as lipid components of the cell.
The acyl-CoA synthetases long-chain (ACSL) stimulates
intracellular free long-chain fatty acids by converting
them to fatty acyl-CoA molecules. Members of the
ACSL family, ACSL 1, 3, 4, 5 and 6 are characterized by
varying subcellular localization, fatty acid substrate and
tissue specificity [4]. ACSL5 is present in various species
including humans and rodents, while also being distrib-
uted in a wide range of tissues including skeletal muscle,
liver, and brain [5]. ACSL5 has been detected in rat liver
cytosol, endoplasmic reticulum and mitochondrial outer
membrane [6]. Increased ACSL5 protein levels have been
observed during food deprivation in rats [6]. Furthermore,
ACSL5 plays a role in facilitating fatty acid channelling
between anabolic lipid synthesis and catabolic β-oxidation
pathway [6, 7]. Previous research conducted in our labora-
tory demonstrated that among 8 polymorphisms along the
ACSL5 gene, only the common single nucleotide poly-
morphism (SNP) rs2419621, found in the promoter re-
gion, displayed a significant association with rate of weight
loss response in women with obesity participating in a
weight management program (which included an ini-
tial 6-week period of 900 kcal meal replacement) [8].
Characterised by a cytosine to thymine transition,
rs2419621 is located 12 nucleotides upstream of the
second transcription start site of ACSL5. The presence of
the [T] allele produces a new cis-regulating E-box site
(DNA binding sites for E-proteins and myogenic regula-
tory factors such as MyoD) at the promoter region of
ACSL5 in addition to the two wildtype E-box elements
[9]. The presence of this extra E-box, has been shown to
increase the amount of MyoD recruited to the ACSL5
promoter in vitro and to increase the expression of the
downstream gene [9]. Furthermore, a 2.2-fold increase of
ACSL5 transcript level was observed in skeletal muscle
biopsies from individuals that are homozygous for the
rs2419621 [T] allele when compared to homozygous wild-
type individuals [8].
The objective of the present study was (1) to validate
the influence of rs2419621 ACSL5 polymorphism on an
independent population of women with obesity (2) To
study the influence of rs2419621 on weight loss and body
composition changes in response to lifestyle interventions
on women with overweight and obesity. This article
reports an increased response in women with overweight
and obesity carrying the ACSL5 rs2419621 [T] allele to
lifestyle interventions in comparison to non-carriers.
Methods
Subjects
Women categorized as being overweight or obese (n = 174)
who participated in two hypocaloric lifestyle intervention
studies Montréal Ottawa New Emerging Team study
(MONET study) and Complication Associated with Obesity
study (CAO study) were examined.
Ethics, consent and permissions
All participants provided informed consent to engage in
the lifestyle intervention as well as to the genetics com-
ponents of these studies. Both cohort studies were ap-
proved by Université de Montréal ethics committee with
agreement to the Declaration of Helsinki.
MONET and CAO intervention studies
The MONET study (n = 137) and the CAO study (n = 37)
recruited women between 2003 and 2007. The MONET
study included postmenopausal women with overweight
or obesity, while the CAO study population was com-
posed of 35 women with obesity and two women with
overweight. Both the MONET and the CAO cohorts and
lifestyle intervention have been previously described and
share major similarities [10]. Briefly, women were eligible
to participate if they met the required criteria including:
(1) Body mass index (BMI) ≥27 kg/m2, (2) menstruation
ceased >1 year and plasma follicle-stimulating hormone
levels ≥30 U l−1, (3) non-diabetic, (4) non-smokers, (5) no
hormone replacement therapy, and (6) <2 h/week of
structured exercise. The aim of MONET and CAO studies
lifestyle intervention was a 10 % body weight reduction
over 6 months. Caloric restriction targets for both studies
were determined by subtracting 500 to 800 kcal from par-
ticipants’ daily energy needs. The daily energy needs were
calculated by multiplying resting metabolic rate of each
participant (determined by indirect calorimetry [11]) to a
physical activity factor of 1.4 as women were not exercis-
ing regularly at the onset of the trial. Dietary prescriptions
ranged from 1100 to 1800 kcal/day. The diet macronutri-
ent composition was 55, 30, and 15 % of energy intake
from carbohydrates, fat, and protein, respectively [11]. A
third of the MONET participants were enrolled in a
resistance-training program whereas the CAO partici-
pants were not enrolled in resistance training. Subjects
from both MONET and CAO studies were combined for
statistical analyses after verifying that there were no sig-
nificant differences between participants’ weight loss and
body composition changes in response to the different
lifestyle interventions.
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Studied variables
Analyses of these variables have been previously de-
scribed [10]. Briefly, body weight measurement was con-
ducted using a calibrated balance (Balance Industrielle
Montréal, Québec, Canada) while other body compos-
ition variables, including fat mass and lean mass, were
measured by Dual-energy X-ray absorptiometry (DXA)
scans using the LUNAR Prodigy system (software ver-
sion 6.10.019; General Electric Lunar Corporation,
Madison, WI, USA). Height was measured using a wall
stadiometer (Perspective Enterprises, Portage, MI, USA)
while BMI was calculated as body weight (kg)/
height(m)2. Visceral fat and thigh muscle attenuation
were measured by computed tomography scan (General
Electric Medical Systems, Milwaukee, WI, USA). Adjust-
ing variables were measured using the COBAS INTE-
GRA 400 analyzer (Roche Diagnostic, Montréal Canada)
for high-density lipoprotein cholesterol (HDL-C), triglyc-
erides and glucose. The Friedwald formula was utilised to
calculate cholesterol (LDL-C) concentration. C-reactive
protein (CRP), haptoglobin, transferrin and orosomucoid
levels were measured by immunonephelometry on an
IMMAGE analyzer (Beckman Coulter, Villepinte, France).
Isolation of DNA and rs2419621 genotyping using
TaqMan MGB probe-based assay chemistry
Isolation of genomic DNA from the blood samples of
individuals who participated in both MONET and CAO
studies, was performed using a Qiagen Flexigene DNA
kit. The ACSL5 rs2419621 SNP (CC, CT, TT) was geno-
typed using the TaqMan MGB probe-based assay chem-
istry (Life Technologies- Applied Biosystems). The PCR
cycle (Biorad’s CFX-96 Real Time PCR) was as follows:
enzyme activation at 95 °C for 10 min., denaturation at
92 °C for 15 s., 60 °C for 1 min-annealing/extension
followed by 39 more repeats from the denaturation step.
A positive control was used in order to ensure reliability
of results. Biorad’s CFX96 real-time system was used for
allelic discrimination while analysis of the data from end
point fluorescence measurements were used to deter-
mine genotypes. Random samples were sequenced (Ap-
plied Biosystem) in order to confirm the genotype.
Statistical analysis
Departure from Hardy-Weinberg proportions was
tested on combined MONET and CAO participants using
a Pearson’s chi-squared test.
Multiple linear regression analyses were conducted on
subjects whose blood samples and biological parameter
measurements (for dependent and adjusting variables)
were available. Multiple linear regression analyses were
conducted on: 1) All MONET and CAO participants
and, 2) MONET and CAO women with obesity only
(BMI ≥30).
Percentage changes in variables following intervention
were calculated by subtracting post-intervention from
baseline values divided by baseline values multiplied by
100. For this study we only had access to the pre and
post-intervention values. Variables studied included
BMI, fat mass, lean mass, visceral fat and thigh muscle
attenuation. Both the absolute values and percentage
values were studied for fat mass and lean mass [percent
fat mass = (fat mass / total body mass) x 100, with total
body mass = fat mass + lean mass; percent lean mass
= (lean mass / total body mass) x 100].
Regression analyses on the data sets for BMI, fat mass,
lean mass, visceral fat and thigh muscle attenuation were
conducted. Best subset regression analysis was con-
ducted to determine which covariables should be in-
cluded and adjusted for in the multiple linear regression
analysis. Specifically we considered the following inde-
pendent variables 1) based on their causative effect on
weight loss: age, baseline weight, height, changes in
transferrin, glucose, CRP, orosomucoid and haptoglobin
2) based on their correlation with weight loss: HDL-C,
LDL-C, triglyceride [8]. The inclusion of a variable that
is correlated with the response can reduce the error vari-
ance and increase the power of the regression analysis.
The selection criteria to determine the best subset of
independent variables was based on the adjusted R-
squared and Mallows Cp. Specifically, we conducted a
best subset regression analysis on data from populations
consisting of women with overweight or obesity (Table 1)
and women with obesity (Table 2). However prior to
conducting any detailed statistical analyses, any extreme
outliers found within the data sets of dependent and
independent variables (if present) were excluded. Ex-
treme outliers were determined based on observed
values with a large standardized residual and large lever-
age. Specifically, one value from haptoglobin, transferrin
and CRP was excluded, while two values were excluded
for orosomucoid.
In order to determine whether MONET & CAO popu-
lations could be pooled together for statistical analysis,
unpaired t-tests were conducted to test for study effect.
Both pre-intervention and post-intervention parameter
values were compared between lifestyle intervention
studies. Multiple linear regression analysis was also con-
ducted in order to observe study effect through the use
of multiple dummy variables on data for women with
overweight or obesity combined. Studies were conducted
comparing CC carriers from the MONET study to CC
carriers from the CAO study. Specifically independent
variables included three dummy variables representing
the subgroups (CAO-CC carriers, CAO-CT/TT carriers
and MONET CT/TT carriers) with the exception of CC
carriers from the MONET study and the covariables that
were determined to be appropriate for adjustment.
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Covariables were determined through best subset regres-
sion models for each dependent variable (Table 1). Simi-
lar analyses were conducted comparing CT/TT carriers
from the MONET study and CT/TT carriers from the
CAO study. Analysis was also conducted on women
with obesity alone using the appropriate covariables.
Covariables were determined by best subset regression
(Table 2).
A multiple linear regression analysis was used to
evaluate the association between ACSL5 rs2419621
genotype and changes in anthropometric and metabolic
characteristics following the lifestyle intervention. A
dominant genetic model (CT/TT vs. CC) was utilized
due to the lack of individuals homozygous for the [T] al-
lele. The multiple linear regression models included the
genotypes as an independent variable. The multiple lin-
ear regression models were conducted on data sets of
dependent variables. Covariables that were included were
only specific to the best subset regression conducted for
each dependent variable (Tables 1 and 2). P-values <0.05
were considered statistically significant. Data analysis was
performed with Minitab software 17.
Results
Comparison of pre- and post-intervention anthropometric
variables' values in each studied cohort and test for
intervention effects
Pre- and post-intervention anthropometric variables from
the MONET and CAO cohorts were compared using
unpaired t-tests (Table 3). No significant differences in
age, height, percent fat and lean mass were found between
the two cohorts pre-intervention. Furthermore, no
significant differences were observed for pre- and post-
intervention absolute values for lean mass, visceral fat,
and thigh muscle attenuation. However, significant differ-
ences were observed between pre- and post-intervention
values for BMI and absolute value of fat mass between the
two cohorts, as well as post-intervention values for per-
cent fat mass and percent lean mass.
When analysing study effects through the use of mul-
tiple linear regression analysis using a general linear
model, no significant difference was observed between
the changes in variables following lifestyle intervention,
between CC carriers in MONET and CAO studies. The
same results were observed between CT/TT carriers in
Table 1 Best subset regression analysis conducted on MONET and CAO women with overweight or obesity
Models of dependent variable studied R-Sq (%) R-Sq (%) (adj) Covariables associated with mentioned R value
Change in BMI 13.1 8.5 Height, change in glucose, change in CRP, change in transferrin and
change in triglyceride
Change in Lean Mass 17.8 12.7 Height, initial weight, change in HDL cholesterol, change in LDL cholesterol,
change in triglyceride, change in glucose
Change in Fat Mass 21.3 16.4 Initial weight, change in glucose, change in CRP, change in transferrin,
change in LDL cholesterol, change in triglyceride
Change in % Fat mass 28.7 23.6 Initial weight, change in HDL cholesterol, change in glucose, change in CRP,
change in transferrin, change in LDL cholesterol, change in triglyceride
Change in % Lean mass 25.0 20.3 Initial weight, change in HDL cholesterol, change in orosomucoid, change in CRP,
change in triglyceride, change in transferrin
Change in Visceral fat 15.9 11.4 Age, height, change in CRP, change in LDL cholesterol, change in triglyceride
Change in Muscle attenuation 14.0 11.0 Height, change in HDL, change in orosomucoid
* Results used to determine covariables for the multiple linear regression analysis. Data sets that were used for dependent variables were data from the MONET
and CAO studies
Table 2 Best subset regression analysis conducted on MONET and CAO women with obesity
Dependent variable studied R-Sq (%) R-Sq (%) (adj) Covariables associated with mentioned R value
Change in BMI 13.2 8.8 Change in transferrin, change in triglyceride and change in orosomucoid
Change in Lean Mass 13.8 8.2 Initial weight, change in HDL cholesterol, change in triglyceride,
change in transferrin and change in CRP
Change in Fat Mass 21.6 15.4 Height, initial weight, change in CRP, change in transferrin, change in triglyceride
Change in % Fat mass 25.4 19.5 Height, initial weight, change in CRP, change in transferrin, change in triglyceride
Change in % Lean mass 25.7 18.7 Height, initial weight, change in HDL cholesterol, change in CRP,
Change in transferrin, change in triglyceride
Change in Visceral fat 21.0 15.9 Age, initial weight, change in CRP and change in triglyceride
Change in Muscle attenuation 17.6 12.3 Change in HDL cholesterol, change in transferrin, change in orosomucoid and
change in haptoglobin
* Results used to determine covariables for the multiple linear regression analysis. Data sets that were used for dependent variables were data from the MONET
and CAO studies
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MONET and CAO studies, illustrating no study effect
between the two cohorts of interest (Tables 4 and 5).
Association analysis between ACSL5 rs2419621 genotype
and changes in anthropometric variables following the
lifestyle intervention
The ACSL5 rs2419621 genotype frequencies were in
Hardy-Weinberg equilibrium (HWE). Data sets were ana-
lyzed using multiple linear regression analysis adjusted for
confounding variables specific to each dependent variable,
to determine the association between rs2419621 genotype
and changes in anthropometric variables following the
lifestyle intervention (Table 6). [T] allele carriers showed a
statistically significant greater decrease in their visceral fat
as well as their absolute and percent fat mass values and a
statistically significant greater increase in their percent
lean mass in comparison to non-carriers following the
interventions.
Comparison of pre- and post-intervention
anthropometric variables' values in women with
obesity from each cohort studied and test for
lifestyle intervention effect
The pre- and post-intervention anthropometric variables'
values from the MONET and CAO cohorts consisting of
only women with obesity were compared using unpaired
t-tests (Table 7). No significant differences were observed
between the different cohorts’ pre- and post-intervention
Table 3 Pre- and post-intervention anthropometric variable values from MONET and CAO women with overweight or obesity
Biological factor observed MONET study CAO study P-value
Mean Std. Dev. Size (n) Mean Std. Dev Size (n)
Age (yrs) 57.9 4.87 106 56.5 4.11 29 0.155
Height (m) 1.61 0.06 106 1.63 0.08 29 0.068
Pre-Intervention
BMI (kg/m2) 32.4 4.74 106 34.3 3.56 29 0.041
Lean Mass (kg) 42.8 6.66 106 45.6 7.44 29 0.054
Fat Mass (kg) 38.5 9.57 106 43.6 9.21 29 0.011
Lean Mass (%) 51.5 4.59 106 49.8 3.62 29 0.072
Fat Mass (%) 45.6 4.70 106 47.2 3.73 29 0.084
Visceral Fat (cm2) 185 54.7 105 200 56.5 29 0.197
Thigh Muscle Attenuation (HU) 48.8 3.34 106 48.2 3.04 29 0.326
Post-Intervention
BMI (kg/m2) 30.3 4.76 105 32.3 3.69 29 0.042
Lean Mass (kg) 41.9 5.70 104 43.6 6.56 29 0.168
Fat Mass (kg) 33.9 10.1 104 40.1 9.51 29 0.004
Lean Mass (%) 54.2 5.36 104 50.9 4.56 29 0.003
Fat Mass (%) 42.6 5.52 104 45.9 4.76 29 0.004
Visceral Fat (cm2) 162 57.7 102 177 51.3 29 0.215
Thigh Muscle Attenuation (HU) 48.6 3.56 105 48.1 3.27 29 0.542
* Results are from unpaired t-tests. Test was conducted on data from all subjects whose blood samples were available for study













R2 R2 (adjusted) Model
p-value
1 Δ BMI 123 0.15 1.55 0.923 0.130 0.069 0.038
2 Δ Lean Mass 124 −2.46 1.51 0.105 0.212 0.150 0.001
3 Δ Fat Mass 121 4.73 3.04 0.123 0.233 0.170 <0.001
4 Δ % Lean Mass 126 −2.98 1.72 0.085 0.268 0.212 <0.001
5 Δ % Fat Mass 121 3.98 2.04 0.053 0.315 0.252 <0.001
6 Δ Visceral Fat 124 2.40 5.41 0.658 0.155 0.096 0.011
7 Δ Muscle attenuation 128 0.10 1.02 0.921 0.134 0.091 0.007
* Multiple linear regression analysis was conducted. Independent variables included three dummy variables (CAO CC Carriers, CAO CT/TT carriers and MONET
CT/TT carriers) with the exception of MONET CC carriers while adjusting for covariables determined by best subset multiple linear regression, independent for
each model (Table 1). The following results illustrate parameter estimates, standard error, p-values corresponding to CAO CC carriers independent variable
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values for any of the biological dependent variables
studied.
A multiple linear regression analysis using a general
linear model was also utilised to test whether body com-
position parameter changes were influenced by lifestyle
interventions. No significant difference was observed
between the changes in outcome variables (specifically
change in BMI, absolute and percent fat mass, absolute
and percent lean mass, visceral fat and muscle attenu-
ation) following the lifestyle intervention, between CC
carriers with obesity in MONET and CC carriers with
obesity in CAO cohorts. Similar results were observed
when studying CT/TT carriers between the two cohorts
illustrating no significant difference between both study
lifestyle interventions (data not shown).
Association analysis between ACSL5 rs2419621 genotype
and changes in anthropometric variables following the
lifestyle intervention in MONET and CAO women with
obesity
Dependent variable data sets were analyzed using mul-
tiple linear regression analysis adjusted for co-variates,
to determine the association between rs2419621 geno-
type and changes in anthropometric variables following
the lifestyle intervention in women with obesity (Table 8).
A statistically significant greater decrease in BMI, absolute
and percent of fat mass values, as well as visceral fat was
noticed following the lifestyle intervention in women with
obesity carrying the [T] allele vs. non-carriers. A statisti-
cally significant greater increase in percent lean mass
values was observed in [T] allele carriers vs. non-carriers
women with obesity following the lifestyle intervention.
Discussion
In 2014, according to the World Health Organization
(WHO), obesity was shown to be present in about 13 %
of the world’s adult population, while 39 % of adults 18+
were overweight, with 40 % of women being overweight
[12]. The objective of this study was to evaluate the
influence of ACSL5 rs2419621 genotype on the changes
in body composition parameters in response to lifestyle
intervention in women with overweight or obesity. In
order to do so, the body composition changes in women
participating in two lifestyle weight-reducing interven-
tions, the MONET (diet and/or resistance training) and
CAO (diet) studies were analyzed according to their
genotype.
Prior to conducting analysis to determine the influence
of rs2419621 genotype, lifestyle intervention-related
changes in body composition parameter differences were
compared between the two cohorts in order to deter-
mine whether they could be combined for statistical













R2 R2 (adjusted) Model
p-value
1 Δ BMI 123 0.36 1.50 0.812 0.130 0.069 0.038
2 Δ Lean Mass 124 −0.35 1.39 0.802 0.212 0.150 0.001
3 Δ Fat Mass 121 2.15 2.92 0.462 0.233 0.170 <0.001
4 Δ % Lean Mass 126 −1.10 1.68 0.513 0.268 0.212 <0.001
5 Δ % Fat Mass 121 1.73 1.89 0.361 0.315 0.252 <0.001
6 Δ Visceral Fat 124 1.28 4.97 0.798 0.155 0.096 0.011
7 Δ Muscle attenuation 128 0.58 0.95 0.543 0.134 0.091 0.007
* Multiple linear regression analysis was conducted. Independent variables included three dummy variables to identify the polymorphism group (CC CAO, CC
MONET and CT/TT CAO) with the exception of CT/TT MONET while adjusting for covariables determined by best subset multiple linear regression, independent for
each model (Table 1). Following results illustrate parameter estimates, standard error, p-values corresponding to CT/TT CAO independent variable













r2 model r2 adjusted model Model
p-value
1 Δ BMI 123 −1.36 0.87 0.121 0.130 0.085 0.012
2 Δ Lean Mass 124 0.93 0.81 0.254 0.193 0.145 0.001
3 Δ Fat Mass 121 −3.82 1.66 0.023 0.213 0.164 <0.001
4 Δ % Lean Mass 126 2.33 0.94 0.014 0.248 0.203 <0.001
5 Δ % Fat Mass 121 −2.99 1.08 0.007 0.287 0.236 <0.001
6 Δ Visceral fat 124 −5.74 2.87 0.048 0.153 0.110 0.003
7 Δ Muscle attenuation 128 0.97 0.56 0.085 0.131 0.103 0.002
* Multiple linear regression analysis was conducted. Parameter estimate of independent variable = Xt was studied. Physiological factors (dependent variables) were
studied while adjusting for confounding factors independent for each model (Table 1). Analysis was conducted on MONET and CAO studies combined
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analyses. The MONET and CAO study population and
designs shared a lot of similarities [10]. Specifically, both
studies used the same hypocaloric diet interventions.
Both studies also included non-diabetic postmenopausal
women, with the MONET study including women with
overweight or obesity, while CAO focused on women
with obesity. A portion (one third) of the MONET study
participants were assigned to resistance training, in
addition to the diet intervention. Furthermore, criteria
for exclusion were similar between studies. Significant
differences were observed between pre and post inter-
vention BMI and absolute fat mass values between the
two cohorts, as well as for percentage of fat mass and
percentage of lean mass in post intervention. These
observations were expected as CAO cohort was nearly
exclusively composed of women with obesity. No signifi-
cant differences in age, height, pre percentage of fat/lean
mass, pre and post values for visceral fat, absolute lean
mass and thigh muscle attenuation were identified. The
significant differences seen in pre and post intervention
values between the cohorts for various outcome vari-
ables studied when women with overweight or obesity
were pooled together, were abolished once the popula-
tion was narrowed down to women with obesity only.
This indicates that rather than observing a study effect,
significant differences observed in the pre and post-
intervention values between MONET and CAO cohorts
consisting of both women with overweight or obesity,
Table 7 Pre- and post-intervention anthropometric variable values from MONET and CAO studies in women with obesity
Biological factor observed MONET study CAO study P-value
Mean Std. Dev. Size (n) Mean Std. Dev Size (n)
Age (yrs) 58.1 4.91 62 56.7 4.18 27 0.230
Height (m) 1.61 0.06 62 1.63 0.08 27 0.189
Pre-Intervention
BMI (kg/m2) 35.3 4.04 62 34.7 3.37 27 0.489
Lean Mass (kg) 45.5 6.82 62 46.1 7.38 27 0.693
Fat Mass (kg) 43.9 8.64 62 44.2 9.10 27 0.898
Lean Mass (%) 49.6 4.43 62 49.7 3.71 27 0.888
Fat Mass (%) 47.6 4.48 62 47.3 3.82 27 0.753
Visceral Fat (cm2) 207 51.9 61 206 52.8 27 0.927
Muscle Attenuation (HU) 48.5 3.70 62 48.6 2.20 27 0.833
Post-Intervention
BMI (kg/m2) 33.0 4.42 61 32.8 3.24 27 0.813
Lean Mass (kg) 44.1 5.69 60 44.1 6.58 27 0.998
Fat Mass (kg) 39.1 9.90 60 41.1 8.78 27 0.361
Lean Mass (%) 51.9 5.28 60 50.4 3.99 27 0.184
Fat Mass (%) 45.1 5.41 60 46.5 4.19 27 0.254
Visceral Fat (cm2) 182 58.5 60 182 47.4 27 0.981
Muscle Attenuation (HU) 48.2 4.09 61 48.6 1.89 27 0.661
* Results are from unpaired t-tests. Test was conducted on data from all subjects whose blood samples were available for study

















1 Δ BMI 87 −2.14 1.05 0.045 0.129 0.087 0.022
2 Δ Lean Mass 85 0.49 1.07 0.645 0.151 0.086 0.041
3 Δ Fat Mass 85 −5.13 1.97 0.011 0.212 0.151 0.004
4 Δ % Lean Mass 85 3.12 1.19 0.010 0.257 0.189 0.001
5 Δ % Fat Mass 85 −3.30 1.30 0.013 0.252 0.194 0.001
6 Δ Visceral fat 85 −9.53 3.47 0.007 0.214 0.164 0.002
7 Δ Muscle attenuation 87 1.20 0.72 0.098 0.177 0.126 0.007
* Multiple linear regression analysis was conducted. Parameter estimate of independent variable = Xt was studied. Physiological factors (dependent variables) were
studied while adjusting for confounding factors independent for each model (Table 2). Analysis was conducted on MONET and CAO studies combined
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was a result of difference in BMI between the two
cohorts, with a much larger proportion of women being
overweight in the MONET cohort.
Association analyses confirmed that women with over-
weight or obesity carrying the [T] allele were more re-
sponsive to the MONET and CAO lifestyle interventions
in comparison to non-carriers. More specifically, carriers
of the [T] allele had a greater decrease in fat mass, while
also displaying a greater increase in lean mass in
comparison to non-carriers. [T] allele carriers also dis-
played a greater decrease in their visceral fat in compari-
son to non-carriers. Furthermore, when considering just
women with obesity, in addition to observing similar
results as the study with individuals with overweight and
obesity, [T] allele carriers also illustrated a greater
decrease in their BMI in comparison to CC individuals.
The results of the present study demonstrate a greater
decrease in visceral fat in carriers of the ACSL5 rs2419621
[T] allele, in comparison to non-carriers when subjected
to lifestyle intervention aimed at weight reduction. Excess
accumulation of visceral fat, characterised as fat packed
between inner organs, is associated with an increased risk
of metabolic syndrome [13]. Various proposed mecha-
nisms, such as the “portal theory” have been suggested to
explain the relationship between visceral adiposity and
common cardiometabolic diseases. Specifically, the “portal
theory” states a rise in lipolytic activity within visceral adi-
pocytes, contributing to an increased delivery of metabolic
by-products such as free fatty acids into the liver, eventu-
ally resulting in insulin resistance [14, 15]. Furthermore,
elevated serum leptin levels are correlated with subcutane-
ous fat but not visceral fat deposition [16]. This decrease
in serum leptin levels observed with omental fat tissue
deposition contributes to a decreased regulation of appe-
tite and impacts energy balance regulation [16].
Individuals with the rs2419621 [T] allele appeared to
have a greater decrease in fat mass and a greater
increase in their lean mass following the intervention, in
comparison to non-carriers. While fat mass encompasses
the overall fat composition of an individual, lean mass
represents non-fat containing tissue mass including bone
connective tissue, skin, organs and the muscle mass of
an individual. Thus carriers of the [T] allele have a
greater loss in fat and increase in lean body mass, in
comparison to non-carriers.
Our results obtained from studying the effects of the
rs2419621 polymorphism on subjects who participated
in the MONET and CAO lifestyle intervention studies,
validate our previous results from the 900-cal/day meal
replacement study [8]. While our previous work focused
on studying the effects of rs2419621 [T] allele carriers
on rate of weight change, the present paper has shown
the effects of the polymorphism on changes in body
composition indices. Furthermore, the results from our
current study illustrate that the rs2419621 polymorph-
ism has a strong effect on subjects’ response to diet/ ex-
ercise intervention, resulting in moderate weight and fat
loss, as statistically significant findings were observed
even with interventions that did not have a strict meal
replacement plan implemented.
At this point, the molecular mechanism by which the
rs2419621 [T] allele exerts its effect is still unknown.
However, the [T] allele has been shown to be associated
with increased ACSL5 expression in rectus femoris
muscle [8]. Furthermore, we showed, in vitro, that the
[T] allele generates a cis-regulatory E-box element rec-
ognized by MyoD, a myogenic regulatory factor [9]. The
[T] allele promotes MyoD-dependent activation of the
ACSL5 promoter, suggesting a direct link between level
of expression of ACSL5 and rs2419621 genotype [9].
Since ACSL5 is known to be mitochondrially localized,
[T] allele carriers might present higher fat oxidation
levels due to increased level of ACSL5.
Conclusion
Based on the observed statistical analyses, carriers of the
ACSL5 rs2419621 [T] allele have been shown to be more
responsive to the MONET and CAO lifestyle interven-
tions in comparison to non-carriers. The strong associ-
ation observed between rs2419621 [T] allele and response
to diet/exercise intervention, has led to the hypothesis of
individuals with the [T] allele having increased fat oxida-
tion in comparison to individuals with the wild type. Our
study confirms and provides additional insights on the
influence of the rs2419621 polymorphism in response to
lifestyle interventions as it is an expansion of the previous
work from Adamo et al. 2007 [8]. However, it should be
noted that population stratification was not controlled for
in our study. As our current study focused on the effect of
rs2419621 on postmenopausal women, future directions
include replicating these findings in a large male popula-
tion or male and female population. Furthermore future
work with in vitro/ in vivo models studying the regulation
of fatty acid β-oxidation by the rs2419621 [T] polymorph-
ism are needed. Such genetic association studies can aid
in designing individualized treatments/interventions for
weight loss catered towards an individual’s genotype spe-
cifically by modifying both diet and exercise.
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